Ligand Pharma (LGND) Shares Add 4+% After Hours as FDA Panel Votes In Favor of Onyx's (ONXX) Carfilzomib
Tweet Send to a Friend
Shares of Ligand Pharma (Nasdaq: LGND) are now up ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
